US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
オーストラリア
ASX
Redivium Ltd (RIL) 銘柄情報

Redivium Ltd (RIL)

0.004

0.00

(0.00%)

終了 6月6日 3:00PM

Redivium Ltd (RIL) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.004

( - )

買値

0.004

売値

0.004

出来高

0.00

0.00 日の範囲 0.00

0.004 52 週間の範囲 0.004

時価総額

前日終値

0.004

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 0.00

発行済株式数

3,402,355,462

配当利回り

PER

-

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-15.59M

Redivium Limited engages in the battery recycling business in Australia. It also involved in mineral exploration activities. The company was formerly known as Hannans Limited and changed its name to Redivium Limited in December 2023. Redivium Limited was incorporated in 2002 and is based in Perth, A... Redivium Limited engages in the battery recycling business in Australia. It also involved in mineral exploration activities. The company was formerly known as Hannans Limited and changed its name to Redivium Limited in December 2023. Redivium Limited was incorporated in 2002 and is based in Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

redivium.com

本社

Perth, Australia

設立

2026

Redivium Ltd is listed in the Materials sector of the オーストラリア証券取引所 with ticker RIL. The last closing price for Redivium was AUD0. Over the last year, Redivium shares have traded in a share price range of AUD 0.004 to AUD 0.004.

Redivium currently has 3,402,355,462 shares in issue. The market capitalisation of Redivium is AUD13.61 million.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0.004	0.004	0.004	0	0	DE
52	0	0	0.004	0.004	0.004	0	0	DE
156	-0.004	-50	0.008	0.008	0.0015	1764316	0.00426914	DE
260	-0.004	-50	0.008	0.008	0.0015	1764316	0.00426914	DE

RIL - Frequently Asked Questions (FAQ)

What is the current Redivium Ltd share price?

The current share price of Redivium Ltd is AUD 0.004

How many Redivium Ltd shares are in issue?

Redivium Ltd has 3,402,355,462 shares in issue

What is the market cap of Redivium Ltd?

The market capitalisation of Redivium Ltd is AUD 13.61M

What is the 1 year trading range for Redivium Ltd share price?

Redivium Ltd has traded in the range of AUD 0.004 to AUD 0.004 during the past year

What is the registered address of Redivium Ltd?

The registered address for Redivium Ltd is 197 St Georges Terrace, Perth, Western Australia, 6000

What is the Redivium Ltd website address?

The website address for Redivium Ltd is redivium.com

Which industry sector does Redivium Ltd operate in?

Redivium Ltd operates in the Mining sector

US Market News

US Market News 4分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 4分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 6分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 9分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 10分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 13分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 13分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 14分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 17分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 18分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 18分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 19分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 20分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 22分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 22分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 22分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 23分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 23分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 23分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 24分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 27分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 29分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

Churchill Capital Corp IV

Euronext Euro 50 ESG EW ...

Ilustrato Pictures (EM)

Amundi Core Global Aggre...

Outlook Therapeutics

Ls 3x Long India Etp

PCI Biotech Holding Asa

American Mobile Dental (EM)

AAB National (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。